Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas
NCT03417765
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Business decision
Conditions
Lymphoma, Non-Hodgkin's, Adult
Lymphoma, Hodgkin's, Adult
Interventions
DRUG:
FE 203799
Sponsor
GlyPharma Therapeutics
Collaborators
[object Object]